D.E. Shaw & Co’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
D.E. Shaw & Co's AVNS Position: Q3 2026 in Review
D.E. Shaw & Co sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 280,729 shares — an estimated $6.98M sold.
D.E. Shaw & Co first reported a position in AVNS in Q4 2014 and held it in 47 quarters. The position peaked at $30.1M in Q1 2022. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.
- D.E. Shaw & Co reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
- D.E. Shaw & Co sold 280,729 Avanos Medical shares in Q3 2026, an estimated $6.98M.
- D.E. Shaw & Co first reported a position in Avanos Medical in Q4 2014 and held it in 47 quarters.
- D.E. Shaw & Co's Avanos Medical position peaked at $30.1M in Q1 2022.
- 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.